Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
7.18
-0.21 (-2.84%)
Mar 6, 2026, 4:00 PM EST - Market closed
Climb Bio Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$13.00
Upside
+81.06%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Maintains $12 → $14 | Buy | Maintains | $12 → $14 | +94.99% | Mar 6, 2026 |
| Baird | Baird | Buy Maintains $9 → $12 | Buy | Maintains | $9 → $12 | +67.13% | Mar 6, 2026 |
| Wedbush | Wedbush | Buy Initiates $12 | Buy | Initiates | $12 | +67.13% | Mar 5, 2026 |
| Piper Sandler | Piper Sandler | Buy Initiates $23 | Buy | Initiates | $23 | +220.33% | Feb 13, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $11 | Strong Buy | Maintains | $9 → $11 | +53.20% | Dec 18, 2025 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Oct 16, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +11.42% | Oct 16, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +25.35% | Oct 13, 2025 |
| BTIG | BTIG | Strong Buy Maintains $7 → $8 | Strong Buy | Maintains | $7 → $8 | +11.42% | Sep 30, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | -2.51% | Sep 22, 2025 |
| Baird | Baird | Buy Initiates $9 | Buy | Initiates | $9 | +25.35% | Aug 15, 2025 |
| Oppenheimer | Oppenheimer | Buy Initiates $10 | Buy | Initiates | $10 | +39.28% | Jun 6, 2025 |